355 related articles for article (PubMed ID: 8477857)
1. Participation of cathepsin L on bone resorption.
Kakegawa H; Nikawa T; Tagami K; Kamioka H; Sumitani K; Kawata T; Drobnic-Kosorok M; Lenarcic B; Turk V; Katunuma N
FEBS Lett; 1993 Apr; 321(2-3):247-50. PubMed ID: 8477857
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and L activities in isolated osteoclasts.
Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
[TBL] [Abstract][Full Text] [Related]
3. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption.
Katunuma N; Matsunaga Y; Matsui A; Kakegawa H; Endo K; Inubushi T; Saibara T; Ohba Y; Kakiuchi T
Adv Enzyme Regul; 1998; 38():235-51. PubMed ID: 9762356
[TBL] [Abstract][Full Text] [Related]
4. Effects of an inhibitor of cathepsin L on bone resorption in thyroparathyroidectomized and ovariectomized rats.
Millest AJ; Breen SA; Loveday BE; Clarkson PN; Simpson CA; Waterton JC; Johnstone D
Bone; 1997 May; 20(5):465-71. PubMed ID: 9145244
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo.
Woo JT; Yamaguchi K; Hayama T; Kobori T; Sigeizumi S; Sugimoto K; Kondo K; Tsuji T; Ohba Y; Tagami K; Sumitani K
Eur J Pharmacol; 1996 Apr; 300(1-2):131-5. PubMed ID: 8741178
[TBL] [Abstract][Full Text] [Related]
6. Specific assay method for the activities of cathepsin L-type cysteine proteinases.
Inubushi T; Kakegawa H; Kishino Y; Katunuma N
J Biochem; 1994 Aug; 116(2):282-4. PubMed ID: 7822244
[TBL] [Abstract][Full Text] [Related]
7. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro.
James IE; Marquis RW; Blake SM; Hwang SM; Gress CJ; Ru Y; Zembryki D; Yamashita DS; McQueney MS; Tomaszek TA; Oh HJ; Gowen M; Veber DF; Lark MW
J Biol Chem; 2001 Apr; 276(15):11507-11. PubMed ID: 11148212
[TBL] [Abstract][Full Text] [Related]
9. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
[TBL] [Abstract][Full Text] [Related]
10. The mechanisms and regulation of procathepsin L secretion from osteoclasts in bone resorption.
Tagami K; Kakegawa H; Kamioka H; Sumitani K; Kawata T; Lenarcic B; Turk V; Katunuma N
FEBS Lett; 1994 Apr; 342(3):308-12. PubMed ID: 8150090
[TBL] [Abstract][Full Text] [Related]
11. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
12. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
Sahara T; Itoh K; Debari K; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
[TBL] [Abstract][Full Text] [Related]
13. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
[TBL] [Abstract][Full Text] [Related]
14. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
15. Secretion and processing mechanisms of procathepsin L in bone resorption.
Kakegawa H; Tagami K; Ohba Y; Sumitani K; Kawata T; Katunuma N
FEBS Lett; 1995 Aug; 370(1-2):78-82. PubMed ID: 7649308
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo.
Moroi R; Yamaza T; Nishiura T; Nishimura Y; Terada Y; Abe K; Himeno M; Tanaka T
Arch Oral Biol; 1997 Apr; 42(4):305-15. PubMed ID: 9222450
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of cathepsins B, D and L in the rat osteoclast.
Goto T; Tsukuba T; Kiyoshima T; Nishimura Y; Kato K; Yamamoto K; Tanaka T
Histochemistry; 1993 May; 99(5):411-4. PubMed ID: 8335484
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
Wilson SR; Peters C; Saftig P; Brömme D
J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
[TBL] [Abstract][Full Text] [Related]
19. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
Lynas JF; Hawthorne SJ; Walker B
Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption.
Yasuma T; Oi S; Choh N; Nomura T; Furuyama N; Nishimura A; Fujisawa Y; Sohda T
J Med Chem; 1998 Oct; 41(22):4301-8. PubMed ID: 9784105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
